Solid Biosciences Inc. (SLDB) Social Stream



Solid Biosciences Inc. (SLDB): $6.28

-0.09 (-1.41%)

POWR Rating

Component Grades

Momentum

B

Stability

C

Sentiment

Quality

D

Add SLDB to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#133 of 381

in industry

SOLID BIOSCIENCES INC (SLDB) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering SLDB.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 6 $17 $5.5 $10.3 $6.25 64.8%
2022-03-14 5 $17 $5.5 $10.3 $6.25 64.8%
2022-03-15 4 $17 $5 $10.2 $6.25 63.2%
2022-04-28 5 $17 $5 $9.4 $6.25 50.4%
2022-05-18 4 $12 $2 $6.5 $6.25 4%
2022-08-11 5 $12 $2 $6.5 $6.25 4%
2022-08-15 5 $12 $2 $6.25 $6.25 0%
2022-10-03 5 $12 $1 $6 $6.25 -4%
2022-10-18 5 $89.955 $14.992 $48.725 $6.25 679.6%
2022-11-11 6 $89.955 $6 $37.383 $6.25 498.13%
2023-01-13 6 $89.955 $6 $32.152 $6.25 414.43%
2023-05-12 6 $89.955 $6 $23.591 $6.25 277.46%

The Trend in the Analyst Price Target


Over the past 22 months, SLDB's average price target has gone up $13.92.

SLDB reports an average of 1,100.68% for its upside potential over the past 39 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-08-12 5 12.000 2.000 6.250 0.80 681.25%
2022-10-18 5 89.955 14.992 48.725 0.47 10267.02%
2022-10-18 5 6.000 1.000 3.250 7.05 -53.9%
2023-01-13 6 89.955 6.000 23.591 6.75 249.5%
2023-05-12 6 89.955 6.000 23.591 6.32 273.28%

SLDB Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 3 0 3 0 0 6

The Trend in the Broker Recommendations


SLDB's average broker recommendation rating improved by 0.5 over the prior 14 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SLDB as an investment opportunity.

  • SOLID BIOSCIENCES INC's variance in analysts' estimates is lower than -1404.52% of all US stocks.
  • SLDB has a higher average analyst price target than 258.38% of all US stocks.
  • In terms of how SOLID BIOSCIENCES INC fares relative to stocks in the small market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 564.63% of that group.
  • SOLID BIOSCIENCES INC's number of analysts covering the stock is greater than 479.59% of Healthcare stocks.

In the Pharmaceutical Products industry, XFOR, APTO, and OTLK are the three stocks most similar to SOLID BIOSCIENCES INC regarding the price target and analyst recommendation information presented here.

Is SLDB a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7483 seconds.